Navigation Links
ConvaTec Names Presidents of Wound Therapeutics and Ostomy Care Business Units
Date:10/29/2008

SKILLMAN, N.J., Oct. 29 /PRNewswire/ -- ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced that Michael E. Steadman will join ConvaTec as President of the company's Wound Therapeutics Business Unit and Nino Pionati has been appointed as President of the company's Ostomy Care Business Unit.

Previously, the company had announced the formation of four new operating divisions -- Ostomy Care, Wound Therapeutics, Continence and Critical Care and Infusion Devices -- following the acquisition of Copenhagen-based Unomedical in September.

In their new roles, Steadman and Pionati will have global responsibility for their respective major business units, which together account for more than 70 percent of the combined company's $1.7 billion (US) annual sales. In addition, they will focus on developing and driving global business strategy and operational excellence to help the company achieve its stated goal of outperforming the market in its focused businesses.

"As ConvaTec moves forward as a stand-alone company under the ownership of Nordic Capital and Avista Capital Partners, we are poised to accelerate growth both above and below the line," said David Johnson, CEO, ConvaTec. "Our new operational structure, driving strategy from a global level while concentrating our delivery and service strengths within markets, will help us achieve our ultimate goal of leadership in each of our four business areas."

Steadman joins ConvaTec from DFB Pharmaceuticals, Inc. where he was Group President and Chief Operating Officer of DFB Branded Pharmaceuticals. Previously, he served as President of Healthpoint, Ltd., a DFB Unit, creating one of the fastest growing pharmaceutical and biologic wound care companies in the world. As President, Wound Therapeutics, Steadman will become part of the ConvaTec Executive Committee.

Pionati has been with ConvaTec since 1998, and most recently served as Senior Vice President, Global Marketing & Business Development. In his new role, he will continue to sit on the ConvaTec Executive Committee. His previous experience includes 15 years with Johnson & Johnson holding various positions of increasing responsibility in medical devices globally.

"We are pleased to welcome Michael to ConvaTec, recognizing his extensive leadership experience in advanced Wound Therapeutics, one of our strongest platforms for future growth," continues Johnson. "Together with Nino's great depth of knowledge and insight into the Ostomy Care market, we are confident that our foundational businesses are now enabled to capitalize on the business opportunities ahead."

About ConvaTec

ConvaTec is a leading developer and marketer of innovative medical technologies that have helped improve the lives of millions of people worldwide. With four key business divisions -- Ostomy Care, Wound Therapeutics, Continence and Critical Care and Infusion Devices -- ConvaTec products support health care professionals from the hospital to the community health setting. From its headquarters in Skillman, New Jersey, the company oversees more than 8,000 employees in over 90 countries serving consumers and their health care professionals on six continents. For more information, please visit http://www.convatec.com.

Contacts:

Nimisha Savani

ConvaTec

Phone: 908-904-2522

Nimisha.Savani@convatec.com

Punnie Donohue

Weber Shandwick

Phone: 212-445-8163

PDonohue@webershandwick.com


'/>"/>
SOURCE ConvaTec
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ConvaTec Launches SUR-FIT Natura(R) Low-Pressure Adaptor
2. WellSpring Pharmaceutical Corp. Names Wendy Shusko as New Chief Operating Officer
3. Vocollect Healthcare Systems Names Michael French as Vice President of Customer Experience
4. CoLucid Pharmaceuticals Names Linda Hogan VP of Business Development
5. The HealthCentral Network Names Jeremy Shane President and Chief Operating Officer
6. Adaptis Names New Sales Executive
7. The Foundation for Biomedical Research Names Dr. Hiram C. Polk Jr. Chairman of its Board of Governors
8. Association of Academic Health Centers Names Texas A&Ms Dr. Nancy W. Dickey Chair of the Board of Directors
9. Using math model, NJIT professor names MVP and Cy Young award contenders
10. Miramar Labs Names Zoromski As CEO
11. Weight Watchers Names Steven C. McCormick as President, North America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/25/2016)... ... 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s ... setting the bar too high can result in disappointment, perhaps even self-loathing. However, those ... goal. , Research from PsychTests.com reveals that behind the tendency to ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... To deal with these feelings, many turn to unhealthy avenues, such as drug or ... Center of Marne, Michigan, has released tools for healthy coping following a traumatic event. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016 According to a ... (Standard Pen Needles, Safety Pen Needles), Needle Length (4mm, ... Hormone), Mode of Purchase (Retail, Non-Retail) - Trends & ... studies the market for the forecast period of 2016 ... 2.81 Billion by 2021 from USD 1.65 Billion in ...
(Date:6/24/2016)... , June 24, 2016 ... appointment of Dr. Edward Futcher to ... Director, effective June 23, 2016.Dr. Futcher was also ... and Governance Committees.  As a non-executive member of ... expertise and strategic counsel to VolitionRx in connection ...
(Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
Breaking Medicine Technology: